Julianne C. Yang
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0001-5898-7221Also affiliated with University of California, Los Angeles
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma”.
Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more
Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more
William Katzka, Julianne C. Yang, Candace Chang, Nerea Arias-Jayo, Venu Lagishetty +9 more
Jonathan P. Jacobs, Ji Won Hwang, Subrata Sabui, Fengting Liang, Hamid M. Said +2 more
William Katzka, Julianne C. Yang, Candace Chang, Nerea Arias-Jayo, Venu Lagishetty +14 more
Allen Louie, Yi Zhou, Rajat Gupta, Fengting Liang, Georgina Xanthou +15 more